日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enzymatic Glucosylation Enhances the Solubility of Niclosamide but Abrogates Its Therapeutic Efficacy

酶促糖基化可提高氯硝柳胺的溶解度,但会降低其治疗效果。

Lax, Brianna M; Escorial García, Martina; Fernandez-Antunez, Carlota; Bukh, Jens; Ramirez, Santseharay; Welner, Ditte Hededam

SARS-CoV-2 Mpro inhibitor ensitrelvir: asymmetrical cross-resistance with nirmatrelvir and emerging resistance hotspots

SARS-CoV-2 Mpro抑制剂恩西替利韦:与尼尔马替利韦存在不对称交叉耐药性及耐药性热点地区出现

Zhou, Yuyong; Gammeltoft, Karen A; Tjørnelund-Sjursen, Helena D; Ryberg, Line A; Offersgaard, Anna; Czarnota, Anna; Duan, Zhe; Pham, Long V; Fahnøe, Ulrik; Peters, Günther H J; Ramirez, Santseharay; Bukh, Jens; Gottwein, Judith M

SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance.

SARS-CoV-2 暴露于瑞德西韦会导致不同的进化路径,最终汇聚成中等程度的耐药性

Fernandez-Antunez Carlota, Ryberg Line A, Wang Kuan, Pham Long V, Mikkelsen Lotte S, Fahnøe Ulrik, Hartmann Katrine T, Jensen Henrik E, Holmbeck Kenn, Bukh Jens, Ramirez Santseharay

Spike substitutions E484D, P812R and Q954H mediate ACE2-independent entry of SARS-CoV-2 across different cell lines.

刺突蛋白的 E484D、P812R 和 Q954H 突变介导 SARS-CoV-2 病毒不依赖 ACE2 进入不同细胞系

Vizgirda Greta, Underwood Alexander P, Fahnøe Ulrik, Weis Nina, Ramirez Santseharay, Bukh Jens

Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions.

SARS-CoV-2 刺突蛋白变种的抗中和作用主要由受体结合域的协同替换介导

Pham Long V, Underwood Alexander P, Binderup Alekxander, Fahnøe Ulrik, Fernandez-Antunez Carlota, Lopez-Mendez Blanca, Ryberg Line Abildgaard, Galli Andrea, Sølund Christina, Weis Nina, Ramirez Santseharay, Bukh Jens

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

首次在人体中使用模块化衣壳病毒样疫苗平台:SARS-CoV-2 疫苗 ABNCoV2 的开放标签、非随机、1 期临床试验

Smit, Merel J; Sander, Adam F; Ariaans, Maud B P A; Fougeroux, Cyrielle; Heinzel, Constanze; Fendel, Rolf; Esen, Meral; Kremsner, Peter G; Ter Heine, Rob; Wertheim, Heiman F; Idorn, Manja; Paludan, Søren Riis; Underwood, Alexander P; Binderup, Alekxander; Ramirez, Santseharay; Bukh, Jens; Soegaard, Max; Erdogan, Sayit M; Gustavsson, Tobias; Clemmensen, Stine; Theander, Thor G; Salanti, Ali; Hamborg, Mette; de Jongh, Willem A; McCall, Matthew B B; Nielsen, Morten A; Mordmüller, Benjamin G

Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination

多次接触SARS-CoV-2抗原感染和/或接种COVID-19疫苗后,中和作用的持久性和广度。

Underwood, Alexander P; Sølund, Christina; Fernandez-Antunez, Carlota; Villadsen, Signe Lysemose; Mikkelsen, Lotte S; Fahnøe, Ulrik; Bollerup, Signe; Winckelmann, Anni Assing; Schneider, Uffe Vest; Binderup, Alekxander; Vizgirda, Greta; Sørensen, Anna-Louise; Vinten, Caroline Nørløv; Dalegaard, Magnus Illum; Ramirez, Santseharay; Weis, Nina; Bukh, Jens

SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses.

SARS-CoV-2 刺突蛋白 HexaPro 采用氢氧化铝配制,并以加速疫苗接种方案进行接种,即使中和抗体反应较低,也能部分保护叙利亚仓鼠免受病毒攻击

Christensen Dennis, Polacek Charlotta, Sheward Daniel J, Hanke Leo, McInerney Gerald, Murrell Ben, Hartmann Katrine Top, Jensen Henrik Elvang, Zimmermann Julie, Jungersen Gregers, Illigen Kristin Engelhart, Isling Louise Krag, Fernandez-Antunez Carlota, Ramirez Santseharay, Bukh Jens, Pedersen Gabriel Kristian

Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.

用于研究抗病毒耐药性和复制的多功能 SARS-CoV-2 反向遗传学系统

Fahnøe Ulrik, Pham Long V, Fernandez-Antunez Carlota, Costa Rui, Rivera-Rangel Lizandro René, Galli Andrea, Feng Shan, Mikkelsen Lotte S, Gottwein Judith M, Scheel Troels K H, Ramirez Santseharay, Bukh Jens

Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA-mRNA or Vector-mRNA COVID-19 Vaccines.

对接种了加强免疫 mRNA-mRNA 或载体-mRNA COVID-19 疫苗的医护人员体内针对 SARS-CoV-2 的中和抗体滴度进行分析

Sølund Christina, Underwood Alexander P, Fernandez-Antunez Carlota, Bollerup Signe, Mikkelsen Lotte S, Villadsen Signe Lysemose, Fahnøe Ulrik, Winckelmann Anni Assing, Feng Shan, Nørløv Vinten Caroline A, Dalegaard Magnus Illum, Vizgirda Greta, Sørensen Anna-Louise, Ramirez Santseharay, Bukh Jens, Weis Nina